BIOCARTIS NV
Desconocido
M3DLoC: Additive Manufacturing of 3D Microfluidic MEMS for Lab on a Chip applications
BIOCARTIS NV
participó en un
H2020:
H2020-IND-CE-2016-17
MEDLOC aims at the employment of multi-material 3D printing technologies for the large-scale fabrication of microfluidic MEMS for lab-on-a-c...
2017-10-30 - 2022-06-30 | Financiado
2017-10-30 - 2022-06-30 | Financiado
ND4ID: New Diagnostics for Infectious Diseases ND4ID
Infectious diseases are a major burden to public health and the global economy, not in the least due to antimicrobial resistance. Rapid poin...
2015-07-31 - 2020-02-29 | Financiado
2015-07-31 - 2020-02-29 | Financiado
SPCard: Development of a fully automated integrated solution that can support a wide range of complex sampl...
BIOCARTIS NV
tramitó un
FP7:
A growing number of molecular diagnostics (MDx) tests help identify risk factors for disease, characterise disease status and subtype, and d...
Financiado
Financiado
PREPARE: Platform foR European Preparedness Against Re emerging Epidemics
BIOCARTIS NV
participó en un
FP7:
Far from receding, the threats posed by infections with epidemic potential grow ever greater. Although Europe has amongst the best healthcar...
Financiado
Financiado
* No se disponen de datos de la empresa actual.